PI3K/mTOR signaling pathway is one of the most frequently activated pathways with alterations in over 70% of human carcinomas including hematologic malignancies and solid tumors such as breast cancer, non-small-cell lung cancer, and endometrial cancer [5–9]. The gene discussed is PIK3CA; the disease is endometrial cancer.